185
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

, &
Pages 625-639 | Published online: 14 Mar 2016

References

  • HollanderEKimSBraunASimeonDZoharJCross-cutting issues and future directions for the OCD spectrumPsychiatry Res200917013619811839
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fifth Ed DSM-5ArlingtonAmerican Psychiatric Association2013
  • EisenJLGoodmanWKKellerMBPatterns of remission and relapse in obsessive-compulsive disorder: a two–year prospective studyJ Clin Psychiatry19996034635110362449
  • SteketeeGHenningerNJPollardCAPredicting treatment outcomes for obsessive-compulsive disorder: effects of comorbidityGoodmanWKRudorferMVMaseJDObsessive-Compulsive Disorder: Contemporary Issues in TreatmentMahwah, NJLawrence Erlbaum Associates2000257274
  • NestadtGSamuelsJRiddleMAThe relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family StudyPsychol Med200131348148711305856
  • Yaryura-ObiasMAPintoANezirogluFThe integration of primary anorexia nervosa and obsessive–compulsive disorderEat Weight Disord2001617418011808812
  • MainaGAlbertUSalviVPessinaEBogettoFEarly-onset obsessive-compulsive disorder and personality disorders in adulthoodPsychiatry Res2008158221722518237785
  • KoranLMGamelNNChoungHWSmithEHAboujaoudeENMirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuationJ Clin Psychiatry200566451552015816795
  • KaplanAHollanderEA review of pharmacologic treatments for obsessive–compulsive disorderPsychiatr Serv20035481111111812883138
  • AbramowitzJSEffectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative reviewJ Consult Clin Psychol19976544529103733
  • van BalkomAJde HaanEvan OppenPSpinhovenPHoogduinKAvan DyckRCognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorderJ Nerv Ment Dis199818684924999717867
  • FoaEBFailure in treating obsessive compulsivesBehav Res Ther199717169176526234
  • SteketeeGShapiroLJPredicting behavioral treatment outline for agoraphobia and obsessive-compulsive disorderClin Psychol Rev199515317346
  • SteketeeGChamblessDLTranmGEffects of Axis I and II comorbidity on behavior therapy outcome for obsessive compulsive disorder and agoraphobiaCompr Psychiatry201142768611154720
  • SalkovskisPMHarrisonJAbnormal and normal obsessions: a replicationBehav Res Ther1984225495526508704
  • PraškoJPaškováBZáleskýRThe effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled studyNeuroendocrinol Lett20062732733216816829
  • BasogluMLaxTKasvikisYMarksIMPredictors of improvement in obsessive-compulsive disorderJ Anxiety Disord19882299317
  • BartlettAEDrummondLMHysterical conversion and dissociation arising as a complication of behavioral psychotherapy treatment of obsessive-compulsive neurosisBr J Med Psychol19906321091151973903
  • GoffDCOlinJAJenikeMABaerLButtolphMLDissociative symptoms in patients with obsessive-compulsive disorderJ Nerv Ment Dis19921803323371583477
  • RuferMHeldDCremerJDissociation as a predictor of cognitive behavior therapy outcome in patients with obsessive-compulsive disorderPsychother Psychosom200675404616361873
  • SpitzerCBarnowSFreybergerHJGrabeHJRecent developments in the theory of dissociationWorld Psychiatry20065828616946940
  • MarchJSFrancesACarpenterDKahnDExpert consensus guidelines: treatment of obsessive compulsive disorderJ Clin Psychol199758172
  • CottrauxJMollardEBouvardMA controlled study of fluvoxamine and exposure in obsessive compulsive disorderInt Clin Psychopharmacol1990517302110206
  • CottrauxJNoteIYaoSNA randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorderPsychother Psychosom20017028829711598428
  • FoaEBSacksMBTolinDFPrezworskiAAmirNInflated perception of responsibility for harm in OCD patients with and without checking compulsions: a replication and extensionJ Anxiety Disord200216444345312213038
  • FoaEBLiebowitzMRKozakMJRandomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorderAm J Psychiatry2005162115116115625214
  • KampmanMKeijsersGPHoogduinCAVerbraakMJAddition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetineActa Psychiatr Scand2002106431431912225499
  • RomanelliRJWuFMGambaRMojtabaiRSegalJBBehavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trialsDepress Anxiety201431864165224390912
  • KozakMJFoaEBMcCarthyPRAssessment of obsessive-compulsive disorder. The NIMH-sponsored collaborative studyGoodmanWKRudorferMVMaserJDObsessive-Compulsive Disorder: Contemporary Issues in TreatmentMahwah, NJLawrence Erlbaum Associates1988501530
  • KeeleyMLStorchEAMerloLJGeffkenGRClinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorderClin Psychol Rev200828111813017531365
  • KarnoMGoldingJMSorensenSBBurnamMAThe prevalence of the obsessive-compulsive disorder in five US communitiesArch Gen Psychiatry198845109410993264144
  • Mataix-ColsDRauchSLManzoPAJenikeMABaerLUse of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorderAm J Psychiatry199915691409141610484953
  • SaxenaSMaidmentKMVapnikTObsessive-compulsive hoarding: symptom severity and response to multimodal treatmentJ Clin Psychiatry200263212711838621
  • PigottTAL’HeureuxFDubbertBBernsteinSMurphyDLObsessive compulsive disorder: comorbid conditionsJ Clin Psychiatry19945515277961529
  • RavizzaLBarzegaGBellinoSBogettoFMainaGPredictors of drug treatment response in obsessive-compulsive disorderJ Clin Psychiatry19955683683737635854
  • AlonsoPMenchonJMPifarreJLong-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapyJ Clin Psychiatry20016253554011488364
  • HantoucheEGBouhassiraMLancrenonSProspective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: Phase III National DRT-TOC StudyEncephale200026738311217541
  • ShettiCNReddyYCKandavelTClinical predictors of drug nonresponse in obsessive-compulsive disorderJ Clin Psychiatry2005661517152316401151
  • SaxenaSBrodyALMaidmentKMBaxterLRJrParoxetine treatment of compulsive hoardingJ Psychiatr Res20074148148716790250
  • DenysDvan NieuwerburghFDeforceDWestenbergHGMPrediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trialJ Clin Psychiatry20076874775317503984
  • Mezinárodní klasifikace nemocí. 10. revizeInternational Classification of the Diseases - 10th editionDuševní poruchy a poruchy chování: Diagnostická kritéria pro výzkum. (přeloženo z anglického originálu)PrahaPsychiatrické centrum1996 Czech
  • SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859suppl 2022339881538
  • AmorimPMini International Neuropsychiatric Interview (MINI): brief interview validation for diagnosing mental disordersRev Bras Psiquiatr2000223106115
  • PinnintiNRMadisonHMusserERissmillerDMINI International Neuropsychiatric Schedule: clinical utility and patient acceptanceEur Psychiatry20031836136414643565
  • GoodmanWKPriceLHRasmussenSAThe Yale-Brown Obsessive Compulsive Scale. II. ValidityArch Gen Psychiatry198946101210162510699
  • GoodmanWKPriceLHRasmussenSAThe Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliabilityArch Gen Psychiatry198946100610112684084
  • RaszkaMPraškoJTintěraJHoráčekJDepersonalizační a derealizační syndrom u pacientky s úzkostně depresivní poruchou v obraze 18FDG PET [Depersonalization and derealization syndrome in patients with anxiety-depressive disorder in the picture of 18FDG PET. Case report]Kazuistika Psychiatrie2009133338 Czech
  • GuyWECDEU Assessment Manual for PsychopharmacologyRockvilleU.S. DHEW1976
  • ZaiderTIHeimbergRGFrescoDMSchneierFRLiebowitzMREvaluation of the Clinical Global Impression Scale among individuals with social anxiety disorderPsychol Med20033361162212785463
  • BeckATEmeryGAnxiety Disorders and Phobias: A Cognitive PerspectiveNew YorkBasic Books1985
  • BeckATEpsteinNBrownGSteerRAAn inventory for measuring clinical anxiety: psychometric propertiesJ Consult Clin Psychol1988568938973204199
  • De AyalaRJVonderharr-CarlsonDJKimDAssessing the reliability of the Beck Anxiety Inventory scoreEduc Psychol Meas200565742756
  • MagánISanzJGarcía-VeraMPPsychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general populationSpan J Psychol200811262664018988448
  • de BeursEWilsonKAChamblessDLGoldsteinAJFeskeUConvergent and divergent validity of the Beck Anxiety Inventory for patients with panic disorder and agoraphobiaDepress Anxiety1997641401469559283
  • BeckATSteerRABallRRanieriWFComparison of Beck depression inventories-IA and -II in psychiatric outpatientsJ Pers Assess19966735885978991972
  • BeckATBeamesderferAAssessment of depression: the depression inventoryMod Probl Pharmacopsychiatry197471511694412100
  • PreissMVaciřKBeckova sebeposuzovací škála depresivity pro dospělé – BDI-II [Beck self-report depression scale for adults – BDI-II]BrnoPsychodiagnostika1999 Czech
  • BernsteinEMPutnamFWDevelopment, reliability, and validity of a dissociation scaleJ Nerv Ment Dis19861747277353783140
  • PtacekRBobPPacltIŠkála disociativních zkuseností – česká verze [Dissociative Experiences Scale – Czech version]Cesk Psychol2006503262272
  • NijenhuisERSSpinhovenPVan DyckRVan der HartOVanderlindenJThe development and psychometric characteristics of the Somatoform Dissociation Questionnaire (SDQ-20)J Nerv Ment Dis19961846886948955682
  • FarinaBMazzottiEPasquiniPNijenhuisEDi GiannantonioMSomatoform and psychoform dissociation among studentsJ Clin Psychol201167766567221433009
  • SheehanDVHarnett-SheehanKRajBAThe measurement of disabilityClin Psychopharmacol199611suppl 38995
  • ColesTCoonCDeMuroCMcLeodLGnanasakthyAPsychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit hyperactivity disorderNeuropsychiatr Dis Treat2014191088789524899807
  • BonhamCAUhlenhuthEDisability and comorbidity: diagnoses and symptoms associated with disability in a clinical population with panic disorderPsychiatry J2014201461972724829902
  • VignePde MenezesGBHarrisonBJFontenelleLFA study of poor insight in social anxiety disorderPsychiatry Res2014219355656124972547
  • CamuriGOldaniLDell’OssoBPrevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorderInt J Psychiatry Clin Pract201418424825425289805
  • PianeGMSmithTCBuilding an evidence base for the co-occurrence of chronic disease and psychiatric distress and impairmentPrev Chronic Dis20142311E18825340360
  • PraškoJJanůLJunekPObsedantně kompulzivní poruchaRabochJUhlikovaPHellerovaPAndersMSustaMVodítka léčebné péče – úzkostné a neurotické poruchy [Obsessive compulsive disorders. Guidelines for treatment care - anxiety and neurotic disorders]PrahaČeská psychiatrická společnost2024113118 Czech
  • NakaoTNakataniENabeyamaMYoshiokaKTomitaMNakagawaADuration effect on neuropsychological function and treatment response of OCDSeishin Shinkeigaku Zasshi2005107121286129816509426
  • KopřivováJCongedoMHoráčekJEEG source analysis in obsessive-compulsive disorderNeurophysiol Clin201112217351743
  • RaszkaMPraskoJKoprivovaJNovakTAdamcovaKPsychological dissociation in obsessive-compulsive disorder is associated with anxiety level but not with severity of obsessive-compulsive symptomsNeuroendocrinol Lett200930562462820035254
  • BellochADel ValleGMorilloCCarrióCCabedoETo seek advice or not to seek advice about the problem: the help-seeking dilemma for obsessive-compulsive disorderSoc Psychiatry Psychiatr Epidemiol200944425726418668187
  • DemetMMDeveciATaşkinEORisk factors for delaying treatment seeking in obsessive-compulsive disorderCompr Psychiatry201051548048520728004
  • SubramaniamMAbdinEVaingankarJAChongSAObsessive – compulsive disorder: prevalence, correlates, help-seeking and quality of life in a multiracial Asian populationSoc Psychiatry Psychiatr Epidemiol201247122035204322526825
  • WangXCuiDWangZCross-sectional comparison of the clinical characteristics of adults with early-onset and late-onset obsessive compulsive disorderJ Affect Disord2012136349850422119088
  • VaingankarJARekhiGSubramaniamMAbdinEChongSAAge of onset of life-time mental disorders and treatment contactSoc Psychiatry Psychiatr Epidemiol201348583584323076588
  • Pena-GarijoJEdo VillamónSMeliá de AlCbaARuipérezMÁPersonality disorders in obsessive-compulsive disorder: a comparative study versus other anxiety disordersScientific World Journal20132185684624453917
  • KampmanMKeijsersGPHoogduinCAHendriksGJA randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy aloneJ Clin Psychiatry200263977277712363116
  • WeissmanMMBlandRCCaninoGJThe cross national epidemiology of obsessive compulsive disorderJ Clin Psychiatry1994553 suppl5108077177
  • HollanderEGreenwaldSNevilleDJohnsonJHornigCDWeissmanMMUncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sampleDepress Anxiety1996–1997431111199166639
  • TorresARMoranPBebbingtonPObsessive-compulsive disorder and personality disorder: evidence from the British National Survey of Psychiatric Morbidity 2000Soc Psychiatry Psychiatr Epidemiol2006411186286716983489
  • PastuchaPPraskoJGrambalALatalovaKSigmundovaZTichackovaADissociative disorder and dissociation – comparison with healthy controlsNeuro Endocrinol Lett200930676977320038932
  • PraskoJRaszkaMDivekyTObsessive compulsive disorder and dissociation – comparison with healthy controlsBiomed Pap20101542179183
  • LochnerCSeedatSHemmingsSMMoolman-SmookJCKiddMSteinDJInvestigating the possible effects of trauma experiences and 5-HTT on the dissociative experiences of patients with OCD using path analysis and multiple regressionNeuropsychobiology200756161317943026
  • BelliHUralCYesilyurtSVardartMKAkbudakMOncuFChildhood trauma and dissociation in patients with obsessive-compulsive disorderWest Indian Med J2013621394424171326
  • SemizUBInancLBezginCHAre trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?Soc Psychiatry Psychiatr Epidemiol20134981287129624213522
  • GavaIBarbuiCAgugliaEPsychological treatments versus treatment as usual for obsessive compulsive disorder (OCD)Cochrane Database Syst Rev2007182CD00533317443583
  • LackCWObsessive-compulsive disorder: evidence-based treatments and future directions for researchWorld J Psychiatry201226869024175173
  • KnoppJKnowlesSBeePLovellKBowerPA systematic review of predictors and moderators of response to psychological therapies in OCD: do we have enough empirical evidence to target treatment?Clin Psychol Rev20133381067108124077387
  • PizarroMFontenelleLFParavidinoDCYücelMMiguelECde MenezesGBAn updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorderExpert Opin Pharmacother201415101391140124766145
  • Thompson-HollandsJEdsonATompsonMCComerJSFamily involvement in the psychological treatment of obsessive-compulsive disorder: a meta-analysisJ Family Psychol201423287298
  • BystritskyAAckermanDLRosenRMAugmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trialJ Clin Psychiatry200465456556815119922
  • StorchEAGoddardAWGrantJEDouble-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorderJ Clin Psychiatry2013746e527e53223842022
  • O’NeillJAugmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCDEvid Based Ment Health2014172585924713316
  • Dell’OssoBBenattiBBuoliMThe influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)Eur Neuropsychopharmacol201323886587123791074
  • VisserHAvan OppenPvan MegenHJEikelenboomMvan BalkomAJObsessive-compulsive disorder; chronic versus non-chronic symptomsJ Affect Disord2014152–15416917424084621
  • OlatunjiBORosenfieldDTartCDCottrauxJPowersMBSmitsJABehavioral versus cognitive treatment of obsessive-compulsive disorder: an examination of outcome and mediators of changeJ Consult Clin Psychol201381341542823421734
  • Mataix-ColsDBomanMMonzaniBPopulation-based, multigenerational family clustering study of obsessive-compulsive disorderJAMA Psychiatry201370770971723699935
  • SteketeeGSievJFamaJMKeshaviahAChosakAWilhelmSPredictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorderDepress Anxiety201128433334121308884
  • EisenJLSibravaNJBoisseauCLFive-year course of obsessive-compulsive disorder: predictors of remission and relapseJ Clin Psychiatry201374323323923561228
  • ShavittRGValérioCFossaluzaVThe impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorderEur Arch Psychiatry Clin Neurosci20102602919920077119
  • PigottTASeaySPharmacotherapy of obsessive-compulsive disorderInt Rev Psychiatry (Abingdon, England)19979133147